These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32713080)

  • 61. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
    Wang K; Xu D; Yan XL; Poston G; Xing BC
    Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Machine Learning Approach to Stratifying Prognosis Relative to Tumor Burden after Resection of Colorectal Liver Metastases: An International Cohort Analysis.
    Paro A; Hyer MJ; Tsilimigras DI; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Aucejo F; Cloyd JM; Pawlik TM
    J Am Coll Surg; 2022 Apr; 234(4):504-513. PubMed ID: 35290269
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Staging and indications for hepatectomy in hepatic metastases of colorectal cancer].
    Kato T; Yasui K; Hirai T; Kanemitsu Y; Komori K
    Nihon Geka Gakkai Zasshi; 2006 May; 107(3):104-8. PubMed ID: 16734265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
    Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
    J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
    J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    Sasaki K; Andreatos N; Margonis GA; He J; Weiss M; Johnston F; Wolfgang C; Antoniou E; Pikoulis E; Pawlik TM
    J Surg Oncol; 2016 Dec; 114(7):803-809. PubMed ID: 27792291
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The primary tumor location impacts survival outcome of colorectal liver metastases after hepatic resection: A systematic review and meta-analysis.
    Liu W; Wang HW; Wang K; Xing BC
    Eur J Surg Oncol; 2019 Aug; 45(8):1349-1356. PubMed ID: 31054852
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases: A population-based national cohort study.
    Scherman P; Syk I; Holmberg E; Naredi P; Rizell M
    Eur J Surg Oncol; 2021 Feb; 47(2):375-383. PubMed ID: 32828581
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.
    Imai K; Castro Benitez C; Allard MA; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
    J Surg Oncol; 2017 Mar; 115(4):488-496. PubMed ID: 28369939
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases.
    Paredes AZ; Hyer JM; Tsilimigras DI; Moro A; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Makris EA; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
    Ann Surg Oncol; 2020 Dec; 27(13):5139-5147. PubMed ID: 32779049
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Colorectal liver metastases with extrahepatic disease--a new criteria for oncologic resection?
    Chua TC; Morris DL
    J Gastrointest Cancer; 2012 Sep; 43(3):502-4. PubMed ID: 21494785
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
    Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
    Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of posthepatectomy liver failure on long-term survival after hepatectomy for colorectal liver metastasis.
    Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Uesaka K
    HPB (Oxford); 2019 Sep; 21(9):1185-1193. PubMed ID: 30777694
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multivisceral Resection for Locally Invasive Colorectal Liver Metastases: Outcomes of a Matched Cohort Analysis.
    Hand F; Sanabria Mateos R; Durand M; Fennelly D; McDermott R; Maguire D; Geoghegan J; Winter D; Hoti E
    Dig Surg; 2018; 35(6):514-519. PubMed ID: 29346790
    [TBL] [Abstract][Full Text] [Related]  

  • 79. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?
    de Haas RJ; Wicherts DA; Flores E; Azoulay D; Castaing D; Adam R
    Ann Surg; 2008 Oct; 248(4):626-37. PubMed ID: 18936576
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Patients With Indeterminate Extrahepatic Disease on 18FDG-PET Scan Before Liver Resection for Metastatic Colorectal Cancer.
    Wong GYM; Kumar R; Beeke C; Ullah S; Chen J; Karapetis C; Price T; Padbury R
    Ann Surg; 2018 May; 267(5):929-935. PubMed ID: 28169837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.